eli lilly lawsuit tirzepatide update FDA will reconsider decision barring copycat versions of weight loss drug Lilly sues four compounders over

What to Expect in the First Few Weeks Each person's response to medication is different, but there are common milestones

Manufacturer savings programs: Eli Lilly will likely offer a savings card similar to Mounjaro's, potentially reducing out-of-pocket costs to $25$50/month for commercially insured patients Projected price: List price estimated at $1,000$1,500/month based on tirzepatide's pricing Brand name: Eli Lilly will give it a commercial brand name (similar to tirzepatide becoming "Mounjaro" and "Zepbound") For more on FDA status, trial progress, and what approval will mean for access and cost, see our guide: Is Retatrutide FDA Approved

Common Gastrointestinal Side Effects The classic incretin-mediated side effects are present with both molecules

Beyond physical discomfort, refined carbs bypass your brain's satiety signals more easily, making portion control harder despite semaglutide's appetite suppression

however, this comes with the trade-off of potentially more severe or prolonged side effects

Obesity | Treatment summaries BNF/NICE